about
Savara Inc is a biopharmaceutical company. It is focused on rare respiratory diseases. The company's program, molgramostim nebulizer solution (molgramostim), is an inhaled granulocyte-macrophage colony-stimulating factor in Phase 3 development for au...
Read More
5.08
-0.07
(-1.36%)
1.0M
XNAS Volume
XNAS 18 Mar, 2026 1:46 PM (EDT)
Board Meeting
The next board meeting for Savara Inc is on 27 Mar 2026 for the purpose of Savara Inc Annual Report for 2025
See details
Not Eligible
Expensive Valuation
Technically Neutral
Savara Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..